◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2389

Beijing Health (Holdings) Limited (2389) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-11

Beijing Health (Holdings) Limited (2389) operates in the Medical Care Facilities industry and is headquartered in Cheung Sha Wan, Hong Kong with about 207 employees. Its market capitalization is roughly HKD 491 million. In the fiscal year ended 2025-12-31, 2389 reported HKD 157M in revenue and (HKD 101M) in net income.

Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People's Republic of China.

Interactive charts & full statements →

2389 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHKD 157MHKD 150MHKD 140MHKD 166M
Gross ProfitHKD 42MHKD 36MHKD 38MHKD 46M
Operating Income (EBIT)(HKD 53M)(HKD 58M)(HKD 63M)(HKD 65M)
Net Income(HKD 101M)(HKD 116M)(HKD 62M)(HKD 98M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2389 Free Cash Flow History

2389 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHKD 2.1BHKD 2.0BHKD 2.2BHKD 2.4B
Total LiabilitiesHKD 343MHKD 210MHKD 224MHKD 272M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2389 viewer.

Other Companies in Medical Care Facilities

← 2388All “0-9” companies2390 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.